Still A Key West African Interest

Goodluck Jonathan, formerly Nigeria's interim president, took office as president on May 6, following the death of Umaru Yar'Adua on May 5. Since the previous president has been incapacitated due to illness since November 2009, our risk ratings and business environment outlooks will remain largely unchanged. Policies in the pipeline when Goodluck Jonathan became acting president will continue, while industrial development is expected to stay on track. Pharmaceutical firms have long regarded Nigeria with interest, chiefly because of its massive middle class population and rising GDP, although we caution that much of that GDP depends on oil revenues. Current plans

To read the full article, please choose one of the following options: